p.99 抽出テキスト

21195678 711. Koyama T, Watanabe H, Terada S, et al. Adaptive servo-ventilation improves renal function in patients with heart failure. Respir Med 2011; 105: 1946-1953. PMID: 21955700 712. Javed F, Tamisier R, Pepin JL, et al. Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE- Heart Failure substudy analysis. Respirology 2020; 25: 305-311. PMID: 31218793 713. Iwaya S, Yoshihisa A, Nodera M, et al. Suppressive effects of adaptive servo-ventilation on ventricular premature complexes with attenuation of sympathetic nervous activity in heart failure patients with sleep-disordered breathing. Heart Vessels 2014; 29: 470-477. PMID: 23836070 714. Miyata M, Yoshihisa A, Suzuki S, et al. Adaptive servo ventilation improves Cheyne-Stokes respiration, cardiac function, and prognosis in chronic heart failure patients with cardiac resynchronization therapy. J Cardiol 2012; 60: 222-227. PMID: 22727431 715. Nakamura S, Asai K, Kubota Y, et al. Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis. Clin Res Cardiol 2015; 104: 208- 216. PMID: 25336356 716. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017; 136: e137-e161. PMID: 28455343 717. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129- 2200. PMID: 27206819 718. O’Connor CM, Whellan DJ, Fiuzat M, et al. Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial. J Am Coll Cardiol 2017; 69: 1577-1587. PMID: 28335841 719. Yamauchi M, Combs D, Parthasarathy S. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med 2016; 374: 689. PMID: 26886532 720. Yang H, Sawyer AM. The effect of adaptive servo ventilation (ASV) on objective and subjective outcomes in Cheyne-Stokes respiration (CSR) with central sleep apnea (CSA) in heart failure (HF): A systematic review. Heart Lung 2016; 45: 199- 211. PMID: 26995256 721. Festic E. Baseline use of antiarrhythmics in patients given adaptive servoventilation: SERVE-HF. Lancet Respir Med 2017; 5: e4. PMID: 28000598 722. Woehrle H, Cowie MR, Eulenburg C, et al. Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF ontreatment analysis. Eur Respir J 2017; 50: 1601692. PMID: 28860264 723. Eulenburg C, Wegscheider K, Woehrle H, et al. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 2016; 4: 873-881. PMID: 27592224 724. Linz D, Fox H, Bitter T, et al. Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies. Clin Res Cardiol 2016; 105: 563- 570. PMID: 26872963 725. Momomura S, Seino Y, Kihara Y, et al. SAVIOR-C investigators. Adaptive servo-ventilation therapy for patients with chronic heart failure in a confirmatory, multicenter, randomized, controlled study. Circ J 2015; 79: 981-990. PMID: 25912560 726. 日本循環器学会,日本心不全学会.心不全症例における ASV 適正使用に関するステートメント(第2 報).http://www.j-circ.or.jp/ information/ASV_tekiseiriyou_rep2.pdf 727. Shigemitsu M, Nishio K, Kusuyama T, et al. Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. Int J Cardiol 2007; 115: 354-360. PMID: 16806535 728. Murase K, Ono K, Yoneda T, et al. Adaptive servoventilation versus oxygen therapy for sleep disordered breathing in patients with heart failure: a randomised trial. Open Heart 2016; 3: e000366. PMID: 27099761 729. The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea (LOFT-HF). ClinicalTrials.gov Identifier: NCT 0 3 7 4 5 8 9 8 . https://clinicaltrials.gov/ct 2 /show/ NCT03745898 730. Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Circulation 2016; 134: 73- 90. PMID: 27358439 731. Lewis GA, Schelbert EB, Williams SG, et al. Biological Phenotypes of Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2017; 70: 2186-2200. PMID: 29050567 732. Sharma K, Kass DA. Heart failure with preserved ejection fraction: Mechanisms, clinical features, and therapies. Circ Res 2014; 115: 79-96. PMID: 24951759 733. Ather S, Chan W, Bozkurt B, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 2012; 59: 998-1005. PMID: 22402071 734. Tomasoni D, Adamo M, Anker MS, et al. Heart failure in the last year: progress and perspective. ESC Heart Fail 2020; 7: 3505- 3530. PMID: 33277825 735. Fu M, Zhou J, Thunström E, et al. Optimizing the Management of Heart Failure With Preserved Ejection Fraction in the Elderly by Targeting Comorbidities (OPTIMIZE-HFPEF). J Card Fail 2016; 22: 539-544. PMID: 26820355 736. Senni M, Paulus WJ, Gavazzi A, et al. New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. Eur Heart J 2014; 35: 2797- 2815. PMID: 25104786 737. Cohen JB, Schrauben SJ, Zhao L, et al. Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone. JACC Heart Fail 2020; 8: 172-184. PMID: 31926856 738. Herrscher TE, Akre H, Øverland B, et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 2011; 17: 420- 425. PMID: 21549300 739. Arikawa T, Toyoda S, Haruyama A, et al. Impact of Obstructive Sleep Apnoea on Heart Failure with Preserved Ejection Fraction. Heart Lung Circ 2016; 25: 435-441. PMID: 26585831 740. Suzuki S, Yoshihisa A, Sato Y, et al. Association between sleepdisordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction. ESC Heart Fail 2018; 5: 284-291. PMID: 29460495 741. Yoshihisa A, Takeishi Y. Sleep Disordered Breathing and Cardiovascular Diseases. J Atheroscler Thromb 2019; 26: 315- 327. PMID: 30814385 742. Dursunoglu D, Dursunoglu N, Evrengül H, et al. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J 2005; 26: 283-288. PMID: 16055877 743. Usui Y, Takata Y, Inoue Y, et al. Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction. Sleep Breath 2012; 16: 677-684. PMID: 21779756 744. Yoshihisa A, Sato Y, Kanno Y, et al. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction. Open Heart 2020; 7: e001112. PMID: 32341787 745. Yamaguchi T, Takata Y, Usui Y, et al. Nocturnal Intermittent Hypoxia Is Associated With Left Ventricular Hypertrophy in Middle-Aged Men With Hypertension and Obstructive Sleep Apnea. Am J Hypertens 2016; 29: 372-378. PMID: 26208670 746. Azarbarzin A, Sands SA, Stone KL, et al. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J 2019; 40: 1149-1157. PMID: 30376054 747. Colish J, Walker JR, Elmayergi N, et al. Obstructive sleep apnea: Effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 2012; 141: 674-681. PMID: 21835901 748. 日本呼吸器学会NPPV ガイドライン作成委員会.NPPV(非侵襲的陽圧換気療法)ガイドライン改訂第2 版.南江堂 2015. 749. Matsumoto H, Kasai T, Suda S, et al. Randomized controlled trial of an oral appliance (SomnoDent) for sleep-disordered breathing and cardiac function in patients with heart failure. Clin Cardiol 2018; 41: 1009-1012. PMID: 30014565 750. Mele D, Nardozza M, Ferrari R. Left ventricular ejection fraction and heart failure: an indissoluble marriage? Eur J Heart Fail 2018; 20: 427-430. PMID: 29314500